Evidence map›Paper›PMID 35214069›Full record

ArticlePharmaceutics2022

Palmitoylethanolamide Promotes White-to-Beige Conversion and Metabolic Reprogramming of Adipocytes: Contribution of PPAR-α.

Chiara Annunziata, Claudio Pirozzi, Adriano Lama, Martina Senzacqua, Federica Comella, Antonella Bordin, Anna Monnolo, Alessandra Pelagalli, Maria Carmela Ferrante, Maria Pina Mollica and 6 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Review
  3. Palmitoylethanolamide in Human and Animal Obesity.Molecules (Basel, Switzerland) · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Chiara AnnunziataDepartment of Pharmacy, School of Medicine, University of Naples Federico II, 80131 Naples, Italy.
Claudio PirozziDepartment of Pharmacy, School of Medicine, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-3409-5744
Adriano LamaDepartment of Pharmacy, School of Medicine, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-5816-1400
Martina SenzacquaDepartment of Experimental and Clinical Medicine, Marche Polytechnic University, 60020 Ancona, Italy.
Federica ComellaDepartment of Pharmacy, School of Medicine, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-5192-3556
Antonella BordinDepartment of Medical-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, Sapienza University of Rome, 04100 Latina, Italy.
Anna MonnoloDepartment of Veterinary Medicine and Animal Production, University of Naples Federico II, 80137 Naples, Italy.
Alessandra PelagalliDepartment of Advanced Biomedical Sciences, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-1133-4300
Maria Carmela FerranteDepartment of Veterinary Medicine and Animal Production, University of Naples Federico II, 80137 Naples, Italy.
Maria Pina MollicaDepartment of Biology, University of Naples Federico II, 80126 Naples, Italy.
Angelo IossaDepartment of Medical-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, Sapienza University of Rome, 04100 Latina, Italy.
Elena De FalcoDepartment of Medical-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, Sapienza University of Rome, 04100 Latina, Italy.ORCID 0000-0002-5220-0587
Giuseppina Mattace RasoDepartment of Pharmacy, School of Medicine, University of Naples Federico II, 80131 Naples, Italy.
Saverio CintiDepartment of Experimental and Clinical Medicine, Marche Polytechnic University, 60020 Ancona, Italy.
Antonio GiordanoDepartment of Experimental and Clinical Medicine, Marche Polytechnic University, 60020 Ancona, Italy.ORCID 0000-0003-1401-5855
Rosaria MeliDepartment of Pharmacy, School of Medicine, University of Naples Federico II, 80131 Naples, Italy.
University of Naples Federico II · ITMarche Polytechnic University · ITSapienza University of Rome · ITClinica Mediterranea · ITInstitute of Biostructure and Bioimaging · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The potential role of brown and beige adipose tissue against obesity has been recognized. Browning, or beiging of white adipose tissue (WAT) is associated with the remodeling of adipocytes and the improvement of their metabolic and secretory functions. Here, palmitoylethanolamide (PEA) restore the plasticity of brown and white adipocytes impaired in mice on a high-fat diet (HFD). Young male C57Bl/6J mice were fed with control (STD) diet or HFD for 12 weeks. Ultramicronized PEA (30 mg/kg/die p.o.) was administered for an additional 7 weeks, together with HFD. PEA recovered interscapular brown fat morphology and function, increasing UCP1 positivity, noradrenergic innervation, and inducing the mRNA transcription of several specialized thermogenic genes. PEA promotes the beige-conversion of the subcutaneous WAT, increasing thermogenic markers and restoring leptin signaling and tissue hormone sensitivity. The pivotal role of lipid-sensing peroxisome proliferator-activated receptor (PPAR)-α in PEA effects was determined in mature 3T3-L1. Moreover, PEA improved mitochondrial bioenergetics in mature adipocytes measured by a Seahorse analyzer and induced metabolic machinery via AMPK phosphorylation. All these outcomes were dampened by the receptor antagonist GW6471. Finally, PEA induced adipogenic differentiation and increased AMPK phosphorylation in human adipose-derived stromal cells (ASCs) obtained from subcutaneous WAT of normal-weight patients and patients with obesity. We identify PEA and PPAR-α activation as the main mechanism by which PEA can rewire energy-storing white into energy-consuming brown-like adipocytes via multiple and converging effects that restore WAT homeostasis and metabolic flexibility.

Indexed as

adipocyte remodelingbeige adipocytesbrown and white adipose tissuehuman adipose stromal cellsleptin signalingperoxisome proliferator-activated receptor-a

Identifiers

PMID35214069
PMCPMC8880285
OpenAlexW4210289768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.